Noticias de AKBA_US

Noticias del mercado

Últimas noticias sobre AKBA_US — 71 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: AKBA_US ✕ 71 resultados
23/04/2026 AKBA_US — MarketBeat
Akebia Therapeutics (NASDAQ:AKBA) Shares Cross Below Two Hundred Day Moving Average - Here's What Happened
23/04/2026 AKBA_US — tayninh.gov.vn
Akebia (AKBA) Road Ahead | Q4 2025: EPS Misses Views - Certified Trade Ideas
22/04/2026 AKBA_US — laocai.gov.vn
Akebia (AKBA) Road Ahead | Q4 2025: EPS Misses Views - Surprise Score
20/04/2026 AKBA_US — tayninh.gov.vn
Akebia (AKBA) Stock: Long-Term Outlook Review (Steady Climb) 2026-04-20 - Verified Analyst Reports
20/04/2026 AKBA_US — haiphong.gov.vn ES ← EN
Acciones de Akebia (AKBA): revisión de perspectivas a largo plazo (aumento constante) 2026-04-20 - Puntos de entrada de expertos
20/04/2026 AKBA_US — laocai.gov.vn ES ← EN
Acciones de Akebia (AKBA): revisión de perspectivas a largo plazo (aumento constante) 2026-04-20 - Puntos de entrada de expertos
18/04/2026 AKBA_US — GuruFocus
Akebia Therapeutics Expects to Resubmit Vadadustat NDA in Third Quarter 2023
18/04/2026 AKBA_US — MSN
H.C. Wainwright Initiates Coverage of Akebia Therapeutics (AKBA) With Buy Rating
17/04/2026 AKBA_US — DirectorsTalk Interviews
Akebia Therapeutics, Inc. (AKBA) Stock Analysis: Potential Upside of 225.93% Draws Investor Attention
17/04/2026 AKBA_US — ChartMill ES ← EN
Pronóstico de AKBA, precio objetivo y calificaciones de analistas | AKEBIA TERAPÉUTICA INC (NASDAQ:AKBA)
16/04/2026 AKBA_US — Intellectia AI ES ← EN
AKBA ¿Debería comprar?
15/04/2026 AKBA_US — MarketBeat
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Given Consensus Rating of "Moderate Buy" by Brokerages
15/04/2026 AKBA_US — Stock Titan
Akebia Therapeutics (NASDAQ: AKBA) asks shareholders to increase authorized stock
13/04/2026 AKBA_US — GuruFocus
Akebia (AKBA) Initiates Phase 1 Trial for AKB-9090 Targeting Kid
13/04/2026 AKBA_US — Yahoo Finance ES ← EN
Akebia Therapeutics lidera el paquete de 3 acciones de centavo prometedoras
13/04/2026 AKBA_US — MarketScreener
Akebia Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of AKB-9090
13/04/2026 AKBA_US — GlobeNewswire ES ← EN
Akebia Therapeutics anuncia los primeros participantes que reciben dosis en el ensayo clínico de fase 1 de AKB-9090
13/04/2026 AKBA_US — Yahoo Finance
Akebia Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of AKB-9090
13/04/2026 AKBA_US — simplywall.st
Akebia Therapeutics Leads The Pack Of 3 Promising Penny Stocks
13/04/2026 AKBA_US — Stock Titan
Akebia starts human testing of drug for kidney injury after heart surgery

Página 1 de 4

keyboard_arrow_up